Clinical Trial Update: Circulating miR-126 as a Novel Biomarker for Post Myocardial Infarction Remodeling

View source ↗

Summary

This completed clinical trial evaluates circulating microRNA-126 as a biomarker for remodeling after myocardial infarction.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Remodeling
• Myocardial Infarction

Snippet

Sponsor: Qilu Hospital of Shandong University | Conditions: Myocardial Infarction, Left Ventricular Remodeling | Status: COMPLETED